Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 22, 2026 09:00 ET | Source: SPR Therapeutics, Inc.

SPR Announces Eight Featured Posters and Presentations at NANS 2026

SPR to feature eight abstracts on SPRINT PNS at the 2026 North American Neuromodulation Society (NANS) Annual Meeting in Las Vegas.
January 21, 2026 07:55 ET | Source: Restore Brain

Restore Brain Announces Expansion of Neuromodulation Footprint with New St. Louis Office, Bringing Advanced TMS and SPRAVATO Treatments to the Region

Dallas-based Restore Brain expands in Missouri, celebrating one year of advanced psychiatric care with innovative TMS and SPRAVATO® treatments.
January 20, 2026 08:00 ET | Source: electroCore, Inc.

electroCore Provides Preliminary Full-Year 2025 Business Update; Expects ~26% Revenue Growth to ~$31.8–$32.0 Million

Record revenue of approximately $31.8 - $32.0 million for full-year 2025 and approximately $9.0 - $9.2 million for the three months ended December 31, 2025 Revenue growth of approximately 26% over...
January 16, 2026 08:00 ET | Source: Curonix LLC

Curonix LLC Announces Commercial Availability of the Freedom® Peripheral Nerve Stimulator (PNS) System as the Only Full-Body PNS Therapy Available in the United States for Craniofacial Pain

Curonix LLC Announces Commercial Availability of the Freedom® Peripheral Nerve Stimulator System as the Only Full-Body PNS Therapy Available in the US
January 12, 2026 06:00 ET | Source: PathMaker Neurosystems Inc.

PathMaker Neurosystems Announces Completion of ALS Early-Feasibility Study of the MyoRegulator® Device for Non-Invasive Treatment of ALS

PathMaker Neurosystems Announces Completion of ALS Early Feasibility Study of the MyoRegulator Device for Non-Invasive Treatment of ALS
January 08, 2026 08:00 ET | Source: NeurAxis, Inc.

NeurAxis Achieves Major Milestone with AMA Category I CPT® Code Now in Effect, Establishing a Permanent Reimbursement Pathway

The new CPT code reflects the latest efficacious medical care available to patients, facilitating adoption and utilization.The assignment of a Category I CPT® code demonstrates a strong message to...
January 07, 2026 20:33 ET | Source: Pulsetto

Best Stress Relief Device 2026: Vagus Nerve Stimulator Consumer Search Analysis as Drug-Free Wellness Interest Expands

Best stress relief device consumer search analysis examines Pulsetto vagus nerve stimulator as January 2026 drug-free wellness interest grows.
December 17, 2025 06:00 ET | Source: PathMaker Neurosystems Inc.

PathMaker Neurosystems Receives FDA Breakthrough Device Designation For Use of the MyoRegulator® Neuromodulation Device in ALS For Slowing the Progression of Functional Symptoms

PathMaker Neurosystems Receives FDA Breakthrough Device Designation For Non-Invasive Treatment of ALS Using the MyoRegulator® Neuromodulation Device
December 01, 2025 07:00 ET | Source: NeurAxis, Inc.

NeurAxis Secures Veterans Affairs Federal Supply Schedule Contract, Broadening Access to More Patients with Functional Abdominal Pain

CARMEL, Ind., Dec. 01, 2025 (GLOBE NEWSWIRE) -- NeurAxis, Inc. (“NeurAxis” or the “Company”) (NYSE American: NRXS), a medical technology company commercializing neuromodulation therapies for chronic...
November 18, 2025 10:33 ET | Source: Research and Markets

Cervical Dystonia Research Analysis Report 2025-2035: Market Sees Intense Competition as Ipsen, Merz, and AbbVie Advance Therapies Through Strategic Expansions

Dublin, Nov. 18, 2025 (GLOBE NEWSWIRE) -- The "Cervical Dystonia Market - A Global and Regional Analysis: Focus on Country and Region - Analysis and Forecast, 2025-2035" report has been added to ...